SRX697782 240N RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples SRP046723 Genomic RNA were then extracted from the dissected tissues using the AllPrep DNA/RNA Mini Kit (cat. no. 80204) from QIAGEN. Only samples with a 260/280 ratio of ~1.8 (DNA) or ~2.0 (RNA) and showing neither degradation nor other contamination on the agarose gels were subjected to further analyses. Sequencing was conducted using the Illumina platform, following the protocols from the manufacturer. SRS1047927 SAMN03024462 RNA-seq_240N RNA-Seq TRANSCRIPTOMIC unspecified 100 0 Application Read Forward 1 1 Application Read Reverse 51 Illumina HiSeq 2000 SRX698154 240T RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples SRP046723 Genomic RNA were then extracted from the dissected tissues using the AllPrep DNA/RNA Mini Kit (cat. no. 80204) from QIAGEN. Only samples with a 260/280 ratio of ~1.8 (DNA) or ~2.0 (RNA) and showing neither degradation nor other contamination on the agarose gels were subjected to further analyses. Sequencing was conducted using the Illumina platform, following the protocols from the manufacturer. SRS698467 RNA-seq_240T RNA-Seq TRANSCRIPTOMIC unspecified 100 0 Application Read Forward 1 1 Application Read Reverse 51 Illumina HiSeq 2000 SRX698155 251T RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples SRP046723 Genomic RNA were then extracted from the dissected tissues using the AllPrep DNA/RNA Mini Kit (cat. no. 80204) from QIAGEN. Only samples with a 260/280 ratio of ~1.8 (DNA) or ~2.0 (RNA) and showing neither degradation nor other contamination on the agarose gels were subjected to further analyses. Sequencing was conducted using the Illumina platform, following the protocols from the manufacturer. SRS698468 RNA-seq_251T RNA-Seq TRANSCRIPTOMIC unspecified 98 0 Application Read Forward 1 1 Application Read Reverse 50 Illumina HiSeq 2000 SRX698156 251N RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples SRP046723 Genomic RNA were then extracted from the dissected tissues using the AllPrep DNA/RNA Mini Kit (cat. no. 80204) from QIAGEN. Only samples with a 260/280 ratio of ~1.8 (DNA) or ~2.0 (RNA) and showing neither degradation nor other contamination on the agarose gels were subjected to further analyses. Sequencing was conducted using the Illumina platform, following the protocols from the manufacturer. SRS698469 RNA-seq_251N RNA-Seq TRANSCRIPTOMIC unspecified 98 0 Application Read Forward 1 1 Application Read Reverse 50 Illumina HiSeq 2000 SRX698157 465T RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples SRP046723 Genomic RNA were then extracted from the dissected tissues using the AllPrep DNA/RNA Mini Kit (cat. no. 80204) from QIAGEN. Only samples with a 260/280 ratio of ~1.8 (DNA) or ~2.0 (RNA) and showing neither degradation nor other contamination on the agarose gels were subjected to further analyses. Sequencing was conducted using the Illumina platform, following the protocols from the manufacturer. SRS698470 RNA-seq_465T RNA-Seq TRANSCRIPTOMIC unspecified 98 0 Application Read Forward 1 1 Application Read Reverse 50 Illumina HiSeq 2000 SRX698158 465N RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples SRP046723 Genomic RNA were then extracted from the dissected tissues using the AllPrep DNA/RNA Mini Kit (cat. no. 80204) from QIAGEN. Only samples with a 260/280 ratio of ~1.8 (DNA) or ~2.0 (RNA) and showing neither degradation nor other contamination on the agarose gels were subjected to further analyses. Sequencing was conducted using the Illumina platform, following the protocols from the manufacturer. SRS698471 RNA-seq_465N RNA-Seq TRANSCRIPTOMIC unspecified 98 0 Application Read Forward 1 1 Application Read Reverse 50 Illumina HiSeq 2000 SRX698159 1172T RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples SRP046723 Genomic RNA were then extracted from the dissected tissues using the AllPrep DNA/RNA Mini Kit (cat. no. 80204) from QIAGEN. Only samples with a 260/280 ratio of ~1.8 (DNA) or ~2.0 (RNA) and showing neither degradation nor other contamination on the agarose gels were subjected to further analyses. Sequencing was conducted using the Illumina platform, following the protocols from the manufacturer. SRS698472 RNA-seq_1172T RNA-Seq TRANSCRIPTOMIC unspecified 98 0 Application Read Forward 1 1 Application Read Reverse 50 Illumina HiSeq 2000 SRX698160 404T RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples SRP046723 Genomic RNA were then extracted from the dissected tissues using the AllPrep DNA/RNA Mini Kit (cat. no. 80204) from QIAGEN. Only samples with a 260/280 ratio of ~1.8 (DNA) or ~2.0 (RNA) and showing neither degradation nor other contamination on the agarose gels were subjected to further analyses. Sequencing was conducted using the Illumina platform, following the protocols from the manufacturer. SRS698473 RNA-seq_404T RNA-Seq TRANSCRIPTOMIC unspecified 98 0 Application Read Forward 1 1 Application Read Reverse 50 Illumina HiSeq 2000 SRX698170 419T_2 RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples 491T_2 RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples SRP046723 Genomic RNA were then extracted from the dissected tissues using the AllPrep DNA/RNA Mini Kit (cat. no. 80204) from QIAGEN. Only samples with a 260/280 ratio of ~1.8 (DNA) or ~2.0 (RNA) and showing neither degradation nor other contamination on the agarose gels were subjected to further analyses. Sequencing was conducted using the Illumina platform, following the protocols from the manufacturer. SRS698475 RNA-seq_419T_2 RNA-Seq TRANSCRIPTOMIC unspecified 100 0 Application Read Forward 1 1 Application Read Reverse 51 Illumina HiSeq 2000 SRX698171 938T RNA-seq of spontaneous canine head and neck squamous cell carcinoma and normal samples SRP046723 Genomic RNA were then extracted from the dissected tissues using the AllPrep DNA/RNA Mini Kit (cat. no. 80204) from QIAGEN. Only samples with a 260/280 ratio of ~1.8 (DNA) or ~2.0 (RNA) and showing neither degradation nor other contamination on the agarose gels were subjected to further analyses. Sequencing was conducted using the Illumina platform, following the protocols from the manufacturer. SRS698474 RNA-seq_938T RNA-Seq TRANSCRIPTOMIC unspecified 100 0 Application Read Forward 1 1 Application Read Reverse 51 Illumina HiSeq 2000